Namik Kemal Universitesi Tip Fakultesi

Tekirdağ 59100

0 studies enrolling now · 3 studies all time

What they study most

Melanoma, Renal Cell Carcinoma (RCC), Secondary Prevention, Stroke

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma — Running, not enrolling
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed